KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Massachusetts

HD5614 • 2025

An Act for long-term coverage of gender affirming care medications

An Act for long-term coverage of gender affirming care medications

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Samantha Montaño
Last action
2026-02-05
Official status
Referred to House Committee on Rules
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act for long-term coverage of gender affirming care medications

An Act for long-term coverage of gender affirming care medications By Representative Montaño of Boston, a petition (subject to Joint Rule 12) of Samantha Montaño relative to long-term coverage of gender affirming care medications.

What This Bill Does

  • An Act for long-term coverage of gender affirming care medications By Representative Montaño of Boston, a petition (subject to Joint Rule 12) of Samantha Montaño relative to long-term coverage of gender affirming care medications.
  • Financial Services.
  • Status: Referred to House Committee on Rules

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-02-05 House

    Referred to the committee on House Rules

Official Summary Text

An Act for long-term coverage of gender affirming care medications
By Representative Montaño of Boston, a petition (subject to Joint Rule 12) of Samantha Montaño relative to long-term coverage of gender affirming care medications. Financial Services.
Status:
Referred to House Committee on Rules

Current Bill Text

Read the full stored bill text 
×

Bill HD.5614

SECTION XX. Section 28 of chapter 32A, as so appearing in the 2022 Official Edition, is hereby amended by adding, after clause (vi), the following clause:- “(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”

SECTION XX. Section 10K of Chapter 118E, as so appearing in the 2022 Official Edition, is hereby amended by adding, after clause (vi), the following clause:- “(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”

SECTION XX. Section 47W of Chapter 175 of the General Laws, as so appearing in the 2022 Official Edition, is hereby amended by adding, after clause (vi), the following clause:- “(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”

SECTION XX. Section 8W of Chapter 176A of the General Laws, as so appearing in the 2022 Official Edition, is hereby amended by adding, after clause (vi), the following clause:- “(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”

SECTION XX. Section 4W of Chapter 176B of the General Laws, as so appearing in the 2022 Official Edition, is hereby amended by adding, after clause (vi), the following clause:- “(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”

SECTION XX. Section 4O of Chapter 176G of the General Laws, as so appearing in the 2022 Official Edition, is hereby amended by adding, after clause (vi), the following clause:- “(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close